Oral VK2735
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Viking Therapeutics · Phase 2 · Completed · Enrollment 280
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo Assignment | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #1) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #2) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #3) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #4) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #5) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #6) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.